PHOTO
Egypt - Kahira Pharmaceuticals and Chemical Industries Company (CPCI) reported a 12% Year on Year (YoY) increase in its net profit in the July-March period of 2012, according to the company’s unaudited financial statements filed to the Egyptian Exchange on May 5th.
The company achieved a net profit of EGP 102.932 million in the July-March period in 2021, compared to EGP 92.234 million in the prior-year period.
The listed company posted a 31.6% YoY rise in its net profit in the first three months of the fiscal year 2019/2020, recording EGP 33.85 million when compared to EGP 25.73 million achieved in the prior-year period.
Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.
Copyright © 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).